Comparative evaluation of Food for Special Dietary Use (FSDU) and Food for Special Medical Purpose (FSMP) product regulatory framework in India, EU and US
Abstract
Nutraceuticals are naturally occurring compounds that is used globally due to its varied health benefits that extends beyond to basic nutrition. Various types of compounds are included in the umbrella term of nutraceuticals, including vitamins, minerals, herbal extracts, and dietary supplements. For better understanding and defined use of specific nutraceuticals in specific conditions, nutraceuticals are classified into various types, including Foods for Special Medicinal Purpose (FSMP) and Foods for Special Dietary Use (FSDU). FSMP are foods or nutraceuticals that are formulated in such a way to meet specific nutritional needs for managing medical conditions. FSMPs are designed to complement medical treatments, aiding in recovery, and improving quality of life. FSDU are formulated to meet the nutritional needs of individuals with specific dietary requirements or restrictions. FSDU are essential for ensuring individuals receive adequate nutrition while adhering to dietary restrictions. The regulatory framework for FSDU and FSMP varies significantly between countries. Each country has its own set of laws and regulations governing the production, labelling, and distribution of these products. These regulations ensure that FSDUs and FSMPs meet specific safety, efficacy, and nutritional standards relevant to local health policies and consumer protection laws. The review aimed to compare the regulatory frameworks for FSMP and FSDU across India, the US, and the EU. It focused on understanding differences in regulatory requirements for these products in each jurisdiction. By analyzing these regulatory landscapes, the study sought to highlight variations that impact manufacturers, healthcare providers, and consumers in these regions.
Downloads
References
https://link.springer.com/article/10.1007/s13555-018-0221-x
2. Andlauer W, Fürst P. Nutraceuticals: a piece of history, present status and outlook. Food Res Int. [Internet] 2002
Jan [cited 2024 June 5]1;35(2-3):171-6. Available from:
https://www.sciencedirect.com/science/article/abs/pii/S096399690100179X
3. Das L, Bhaumik E, Raychaudhuri U, Chakraborty R. Role of nutraceuticals in human health. J Food Sci Tech. [Internet] 2012 Apr [cited 2024 June 5];49:173-83. Available from:
https://link.springer.com/article/10.1007/s13197-011-0269-4
4. Sachdeva V, Roy A, Bharadvaja N. Current prospects of nutraceuticals: A review. Curr Pharma Biotechnol. [Internet] 2020 Aug [cited 2024 June 5]1;21(10):884-96. Available from:
https://www.ingentaconnect.com/content/ben/cpb/2020/00000021/00000010/art00003
5. Casale R, Symeonidou Z, Ferfeli S, Micheli F, Scarsella P, Paladini A. Food for special medical purposes and nutraceuticals for pain: a narrative review. Pain Ther. [Internet] 2021 Jun[cited 2024 June 5];10:225-42. Available from:
https://link.springer.com/article/10.1007/s40122-021-00239-y
6. Ullah H, Khan A, Daglia M. The focus on foods for special medical purposes and food supplements in age‐related disorders. Food Front. [Internet] 2022 Sep[cited 2024 June 5];3(3):353-7. Available from:
https://onlinelibrary.wiley.com/doi/abs/10.1002/fft2.163
7. Food Safety and Standards Authority, Guidance Note on Food for Special Medical Purpose (FSMP). [Internet]
[cited 2024 June 5] Available from:
https://www.fssai.gov.in/upload/uploadfiles/files/Guidance_Note_FSMP_28_08_2020.pdf
8. FSMP introduction in Europe [Internet]; [cited on 2024 Feb 20]. Available from: https://www.efsa.europa.eu/en
9. FSG Regulation [Internet]; [cited on 2024 Feb 20]. Available from:
https://eur-lex.europa.eu/EN/legal- content/summary/foods-for- specificgroups.html#:~:text=The%20regulation%20also%20vests%20the,for%20special%20medical%20purposes%3 B%20and
10. FSMP introduction in US [Internet]; [cited on 2024 Feb 20]. Available from:
https://www.fda.gov/media/83372/download#:~:text=Orphan%20Drug%20Definition%20An%20orphan,following% 20approval%20by%20the%20FD
11. Regulatory framework of FSMP in US [Internet]; [cited on 2024 Feb 20]. Available from:
https://www.fda.gov/media/83372/download#:~:text=Orphan%20Drug%20Definition%20An%20orphan,following% 20approval%20by%20the%20FD
12. Mäkinen OE, Wanhalinna V, Zannini E, Arendt EK. Foods for special dietary needs: Non-dairy plant-based milk substitutes and fermented dairy-type products. Crit Rev Food Sci Nutr. [Internet]2016 Feb 17[cited on 2024 Feb 20];56(3):339-49. Available from:
https://www.tandfonline.com/doi/abs/10.1080/10408398.2012.761950
13. Pennington JA, Vanderveen JE. Descriptive terms for foods with special dietary characteristics. J Nutr Edu. [Internet] 1988 Feb[cited on 2024 Feb 20]1;20(1):30-2. Available from:
https://www.sciencedirect.com/science/article/abs/pii/S0022318288802991
14. Frequently Asked Questions (FAQs) on the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 (herein after referred as Nutraceutical Regulations) [Internet]; [cited on 2024 Feb 20]. Available from: https://fssai.gov.in/upload/uploadfiles/files/FAQs_Nutraceutical_Regulations_06_10_2020.pdf
15. FSDU regulations in US [Internet]; [cited on 2024 Feb 20]. Available from: https://healthcarenutrition.org/wp- content/uploads/2019/09/HNC-MFW-OConnell-FSDU.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
